2001
DOI: 10.1016/s0021-9150(01)00530-5
|View full text |Cite
|
Sign up to set email alerts
|

Retinoic acid suppresses endothelin-1 gene expression at the transcription level in endothelial cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
26
0
1

Year Published

2004
2004
2018
2018

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 23 publications
(29 citation statements)
references
References 22 publications
2
26
0
1
Order By: Relevance
“…Typically, targets are upregulated by RA not down-regulated as described here for Tbx1, although down-regulation of endothelin-1, a Tbx1 target gene, (Piotrowski et al, 2003), has been described in endothelial cells 8 hr after the addition of RA (Yokota et al, 2001). As some of the repression we observed was dependent upon de novo protein synthesis, it is possible that an intermediary transcriptional repressor is involved.…”
Section: Discussionmentioning
confidence: 53%
“…Typically, targets are upregulated by RA not down-regulated as described here for Tbx1, although down-regulation of endothelin-1, a Tbx1 target gene, (Piotrowski et al, 2003), has been described in endothelial cells 8 hr after the addition of RA (Yokota et al, 2001). As some of the repression we observed was dependent upon de novo protein synthesis, it is possible that an intermediary transcriptional repressor is involved.…”
Section: Discussionmentioning
confidence: 53%
“…It also has several biological activities that promote the synthesis of vasorelaxant molecules (17) and inhibit the action of vasoconstrictor agents (19)(20)(21). In addition, it exhibits antithrombotic and antiatherogenic potential (18,(22)(23)(24)(25)(26)(27)(28)(29)(30)(31).…”
Section: Discussionmentioning
confidence: 99%
“…Retinoids also exhibit putatively beneficial biological actions in the cardiovascular system. They increase NO synthesis, modulate hemostatic properties and inhibit endothelin-1 expression in ECs (17)(18)(19), inhibit actions of angiotensin II and TXA 2 receptor expression in vascular SMCs (20,21), reduce monocyte tissue factor (TF) and TF/factor VIIa-dependent arterial thrombosis (22), and exhibit beneficial actions in cardiovascular disease models (23)(24)(25)(26)(27)(28)(29)(30)(31).…”
mentioning
confidence: 99%
“…Les acides rétinoïques inhibent la croissance cellulaire, et ont donc une action anti-athérogène potentielle dans les vaisseaux. Les acides rétinoïques répriment égale-ment l'expression de l'ARNm codant pour la PPET-1 et l'activité transcriptionnelle de son promoteur [14]. Ces résultats suggèrent que les rétinoïdes pourraient être des modulateurs de la fonction endothéliale.…”
Section: Modulation Du Système Endothélineunclassified